Managed Care - May 2008 - (Page I1)
CLINICAL BRIEFS Tumor Necrosis Factor (TNF) Inhibitors A review of structure, function, and mechanism of action By Joseph Flood, MD, FACR President, Musculoskeletal Medical Specialists Inc.; Clinical faculty member, The Ohio State University College of Medicine and Public Health, Columbus Supplement to Volume 17, No. 5 Supplement 4 May 2008 This publication is supported by Amgen
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.